secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001171843-26-001971
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Texas Prostate hits 100th TULSA Procedure; volumes up 500% under new Medicare model
--------------------------------------------------------------------------------

- Texas Prostate, led by Dr. James Cochran, performed its 100th TULSA Procedure at Dallas Medical Center.
- Procedure volumes increased 500% after transitioning from private pay to a Medicare model via Dallas Medical Center.
- Dr. Cochran cited TULSA's MRI-guidance and thermography for broader treatment range and improved safety versus HIFU.
- CEO Arun Menawat said the model demonstrates a path for accelerating TULSA adoption across prostate care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/0001171843-26-001971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/f8k_032726.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer